期刊
DEVELOPMENTAL DYNAMICS
卷 232, 期 1, 页码 221-231出版社
WILEY
DOI: 10.1002/dvdy.20221
关键词
metalloprotease-disintegrin; ADAM; MS2; CD156a; lymphatic development
资金
- NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER
- NCI NIH HHS [P30-CA-08748] Funding Source: Medline
- NIGMS NIH HHS [R01 GM064750-04, R01 GM65740, R01 GM064750] Funding Source: Medline
ADAMS (a disintegrin and metalloprotease 8, also referred to as MS2/CD156a) is a membrane-anchored metalloprotease that was first identified in a macrophage cell line and has been implicated in neurodegenerative diseases. Here, we evaluated the expression of ADAMS during mouse development and generated mice lacking ADAMS (Adam8-/- mice). During early mouse development, ADAMS is expressed by maternal cells in the decidua and by trophoblast derivatives of the embryo but not in the derivatives of the inner cell mass. At later stages, prominent expression of ADAMS is seen in the embryo proper, in the gonadal ridge, thymus, developing cartilage and bone, brain and spinal cord, and in the mesenchyme in close proximity to the branch point between the jugular vein and developing lymphatic vessels. Examination of Adam8-/- mice, however, revealed no major defects in these or other structures during development or in adult tissues and no evident pathological phenotypes. (C) 2004 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据